Goertz, Lukas
Liebig, Thomas
Siebert, Eberhard
Dorn, Franziska
Pflaeging, Muriel
Forbrig, Robert
Pennig, Lenhard
Schlamann, Marc
Kabbasch, Christoph
Funding for this research was provided by:
Universitätsklinikum Köln
Article History
Received: 10 February 2022
Accepted: 15 June 2022
First Online: 6 July 2022
Competing interests
: CK serves as consultant for Acandis GmbH (Pforzheim, Germany) and as proctor for MicroVention Inc./Sequent Medical (Aliso Viejo, CA, USA). TL serves as proctor for MicroVention Inc./Sequent Medical (Aliso Viejo, CA, USA), CERUS Endovascular (Fremont, CA, USA), Phenox (Bochum, Germany), Stryker (Kalamazoo, MI, USA), and Medtronic (Dublin, Ireland). The other authors declare that they have no competing interests.